Quick Answer
Rein Therapeutics, Inc. reported Total Assets of $24.16 million for fiscal year 2025.
Rein Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $24.16M | -61.2% |
| 2024 | $62.19M | -41.3% |
| 2023 | $106.01M | +381.7% |
| 2022 | $22.01M | -54.6% |
| 2021 | $48.48M | +196.7% |
| 2020 | $16.34M | -38.3% |
| 2019 | $26.47M | -12.7% |
| 2018 | $30.31M | -42.5% |
| 2017 | $52.69M | +139.3% |
| 2016 | $22.02M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $53.71M | -48.5% | -6.6% |
| June 30, 2025 | $57.48M | -47.5% | -0.3% |
| March 31, 2025 | $57.63M | -41.9% | -7.3% |
| December 31, 2024 | $62.19M | -41.3% | -40.3% |
| September 30, 2024 | $104.22M | +712.8% | -4.7% |
| June 30, 2024 | $109.40M | +681.9% | +10.3% |
| March 31, 2024 | $99.19M | +478.1% | -6.4% |
| December 31, 2023 | $106.01M | +381.7% | +726.8% |
- Rein Therapeutics, Inc. showed a decrease of -61.2% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Rein Therapeutics, Inc.’s total assets has grown by 9.7% (from $22.02 million to $24.16 million).
- The most recent figure is from Rein Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: